Severe thymic atrophy in a mouse model of skin inflammation accounts for impaired TNFR1 signaling

PLoS One. 2012;7(10):e47321. doi: 10.1371/journal.pone.0047321. Epub 2012 Oct 11.

Abstract

Transgenic mice expressing the caspase-cleaved form of the tyrosine kinase Lyn (LynΔN) develop a TNFα-dependent skin disease that accurately recapitulates human psoriasis. Participation of lymphocytes in this disease was confirmed by backcrossing LynΔN mice on a Rag-1 deficient background. The present study was therefore conducted to analyze whether modification of lymphocyte homeostasis does occur and participate in the phenotype of LynΔN mice. We show here that LynΔN mice consistently exhibit thymic atrophy that correlates with both a net decrease in the CD4+/CD8+ Double Positive (DP) and an increase in Single Positive (SP) thymocyte sub-populations, but also display an increase of splenic mature B cell. Interestingly, a normal immune phenotype was rescued in a TNFR1 deficient background. Finally, none of these immune alterations was detected in newborn mice before the onset of inflammation. Therefore, we conclude that chronic inflammation can induce thymic atrophy and perturb spleen homeostasis in LynΔN mice through the increased production of TNFα, LTß and TNFR1 signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atrophy / physiopathology
  • B-Lymphocytes / cytology
  • Bromodeoxyuridine
  • Dermatitis / genetics
  • Dermatitis / physiopathology*
  • Flow Cytometry
  • Immunoblotting
  • In Situ Nick-End Labeling
  • Mice
  • Mice, Transgenic
  • Receptors, Tumor Necrosis Factor, Type I / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction / physiology*
  • T-Lymphocyte Subsets / cytology
  • Thymus Gland / cytology
  • Thymus Gland / pathology*
  • Tumor Necrosis Factor-alpha / metabolism
  • src-Family Kinases / genetics*

Substances

  • Receptors, Tumor Necrosis Factor, Type I
  • Tnfrsf1a protein, mouse
  • Tumor Necrosis Factor-alpha
  • lyn protein-tyrosine kinase
  • src-Family Kinases
  • Bromodeoxyuridine

Grants and funding

This work was supported by Inserm, la Ligue Nationale contre le Cancer (Equipe Labelisée 2011–2013), la Fondation de France and la Fondation pour la Recherche Médicale (DMP20101120387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MJ, MB and DG are recipients of fellowships from the Fondation pour la Recherche Médicale. AJ is recipient of fellowship of the Ligne Nationale Contre le Cancer. JER’s team is supported by an ANR grant (ANR-09-JCJC-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.